Weed P/B
The P/B (Price-to-Book Ratio) of Weed (BUDZ) as of Jul 26, 2026 is -7.21. In the previous year, P/B (Price-to-Book Ratio) was -22.45 — a change of -67.89% (higher).
Get this data via API
Financial Data API
P/B
-7.21
YoY
-67.89%
Last updated:
P/B (Price-to-Book Ratio) of Weed is 2026 -7.21 . P/B (Price-to-Book Ratio) of Weed was 2025 -22.45 . It decreases by -67.89% higher compared to the previous year.
Access this data via the Eulerpool API
Weed Stock analysis
What does Weed do? Weed Inc is a company that operates in the cannabis industry. The company was founded in 2016 and is based in California, USA. The founders of Weed Inc. have extensive experience in growing, processing, and distributing marijuana.
Weed Inc's business model is very diverse. They have different divisions such as cultivation, processing, distribution, and marketing. The company's focus is on the cultivation of medical marijuana, which is legal in many US states. The company specializes in the production and sale of high-quality cannabinoid products, also known as cannabis oil or hemp oil.
Weed Inc. values sustainability and environmental responsibility. Their philosophy includes protecting the environment and natural resources. They use only biodegradable products to minimize environmental impact.
Another important division of Weed Inc. is the distribution of medical marijuana. The company sells its products to licensed doctors and pharmacies, who then distribute them to patients. Cannabis has emerged in recent years as a therapeutic alternative to conventional medications and can be used for various health issues such as chronic pain and social anxiety.
In addition to growing and selling medical marijuana, Weed Inc. offers other products. These include plants, fertilizers, and other products for plant care, as well as vaporizers and other cannabis consumption devices.
Weed Inc. has established itself as an innovator in the industry and is always looking for new products and markets. The company operates in the USA, Canada, and Europe, and plans to expand into other countries in the near future.
In summary, Weed Inc. is a company that operates in the cannabis industry and specializes in the cultivation and sale of medical marijuana and cannabinoid products. The company values environmentally conscious practices and strives to produce its products sustainably and ecologically. Other products offered by Weed Inc. include plants, fertilizers, and vaporizers. Weed is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Weed stock
P/B (Price-to-Book Ratio) of Weed is -7.21 in 2026.
Access this data via the Eulerpool API
Valuation — Weed
All Key Metrics — Weed
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth